期刊文献+

强化胰岛素治疗老年脓毒症114例临床分析 被引量:7

Intensive insulin therapy for elderly patients with sepsis:report of 114 cases
下载PDF
导出
摘要 目的探讨强化胰岛素治疗老年脓毒症患者的临床疗效。方法114例发生脓毒症的老年(>60岁)患者随机分为强化胰岛素治疗组(研究组)59例,常规胰岛素治疗组(对照组)55例。血糖控制目标值:研究组为4.4~8.3mmol/L,对照组为10~11.1mmol/L,两组其余临床治疗均相同。监测血清C反应蛋白水平变化、抗生素应用时间、院内新发感染发生率、血管活性药物应用量、需要血液净化治疗的急性肾衰竭的发生率和28d生存率等指标。结果与对照组比较,研究组老年脓毒症患者的C反应蛋白水平、抗生素应用时间、院内新发感染发生率、血管活性药物应用量、需要血液净化治疗的急性肾衰竭的发生率显著降低,28d生存率提高,且差异有统计学意义。治疗组低血糖发生例数多于对照组。结论对于老年脓毒症患者,早期强化胰岛素治疗能更加及时有效地控制血糖,并改善临床疗效。 Objective To observe the clinical effects of intensive insulin therapy in elderly patients with sepsis. Methods A total of 114 patients (60 years) with sepsis were randomly divided into two groups,intensive insulin therapy group (n=59) and routine insulin therapy group (n=55). The blood glucose was controlled within 4.4-8.3 mmol/L in intensive insulin group,and 10.0-11.1 mmol/L in routine insulin therapy group. Other therapies were identical in two groups. The serum C-reactive protein (CRP) level,duration for antibiotic usage,hospital-acquired infection rate,amount of vasopressors used,incidence of acute renal failure requiring blood purification,28-day survival rate were recorded. Results In intensive insulin therapy group,the serum CRP level,duration for antibiotic usage,hospital-acquired infection rate,amount of vasopressors used,and incidence of acute renal failure requiring blood purification were significantly reduced,and 28-day survival rate was significantly elevated,compared with routine insulin therapy group. Conclusion For elderly patients with sepsis,early intensive insulin therapy can control blood glucose more effectively and timely,and can improve the clinical therapeutic effects.
出处 《中华老年多器官疾病杂志》 2010年第1期61-64,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 脓毒症 老年 强化胰岛素治疗 sepsis eldly intensive insulin therapy
  • 相关文献

参考文献15

  • 1Shapiro N,Howell MD,Bates DW,et al.The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection[J].Ann Emerg Med,2006,48 (5):583-590.
  • 2Kleinpell RM,Graves BT,Ackerman MH.Incidence,pathogenesis,and management of sepsis:an overview[J].AACN Adv Crit Care,2006,17(4):385-393.
  • 3Yendamuri S,Fulda GJ,Tinkoff GH.Admission hy-perglycemia as a prognostic indicator in trauma[J].J Trauma,2003,55(1):33-38.
  • 4Laird AM,Miller PR,Kilgo PD,et al.Relationship of early hyperglycemia to mortality in trauma patients[J].J Trauma,2004,56(5):1058-1062.
  • 5Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J].Crit Care Med,2003,31(4):1250-1256.
  • 6Frankenfield D,Cooney RN,Smith JS,et al.Age-related differences in the metabolic response to injury[J].J Trauma,2000,48(1):49-56.
  • 7Umpierrez GE,Isaaes SD,Bazargan N,et al.Hyperglycemia:an independent marker of in-hospital mortality in patients with undiagnosed diabetes[J].J Clin Endocrinol Metab,2002,87(3):978-982.
  • 8Wilson M,W winreb J,Hop GW.Intensive insulin therapy in critical care:a review of 12 protocols[J].Diabetes Care,2007,30(4):1005-1011.
  • 9Van-Den-Berghe G,Wouters P,Weekers F,et al.In-tensive insulin therapy in the critically ill patients[J].N Engl J Med,2001,345(19):1359-1367.
  • 10Finney SJ,Zekveld C,Elia A,et al.Glucose control and mortality in critically ill patients[J].JAMA,2003,290(15):2041-2047.

同被引文献68

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部